These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 32009263)

  • 21. Reduction of inappropriate anti-tachycardia pacing therapies and shocks by a novel suite of detection algorithms in heart failure patients with cardiac resynchronization therapy defibrillators: a historical comparison of a prospective database.
    Lunati M; Proclemer A; Boriani G; Landolina M; Locati E; Rordorf R; Daleffe E; Ricci RP; Catanzariti D; Tomasi L; Gulizia M; Baccillieri MS; Molon G; Gasparini M;
    Europace; 2016 Sep; 18(9):1391-8. PubMed ID: 26826135
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of a Device-Based Continuous Optimization Algorithm for Patients With Cardiac Resynchronization Therapy.
    Ueda N; Noda T; Ishibashi K; Nakajima K; Kataoka N; Kamakura T; Wada M; Yamagata K; Inoue Y; Miyamoto K; Nagase S; Aiba T; Kanzaki H; Izumi C; Noguchi T; Yasuda S; Kusano K
    Circ J; 2019 Dec; 84(1):18-25. PubMed ID: 31656236
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Atrial fibrillation in recipients of cardiac resynchronization therapy device: 1-year results of the randomized MASCOT trial.
    Padeletti L; Muto C; Maounis T; Schuchert A; Bongiorni MG; Frank R; Vesterlund T; Brachmann J; Vicentini A; Jauvert G; Tadeo G; Gras D; Lisi F; Dello Russo A; Rey JL; Boulogne E; Ricciardi G;
    Am Heart J; 2008 Sep; 156(3):520-6. PubMed ID: 18760135
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of automatic frequent pace-timing adjustments on effective left ventricular pacing during cardiac resynchronization therapy.
    Varma N; Stadler RW; Ghosh S; Kloppe A
    Europace; 2017 May; 19(5):831-837. PubMed ID: 27230561
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel algorithm increases the delivery of effective cardiac resynchronization therapy during atrial fibrillation: The CRTee randomized crossover trial.
    Plummer CJ; Frank CM; Bári Z; Al Hebaishi YS; Klepfer RN; Stadler RW; Ghosh S; Liu S; Mittal S
    Heart Rhythm; 2018 Mar; 15(3):369-375. PubMed ID: 29132930
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Determinants of New-Onset Atrial Fibrillation in Patients Receiving CRT: Mechanistic Insights From Speckle Tracking Imaging.
    Sade LE; Atar I; Özin B; Yüce D; Müderrisoğlu H
    JACC Cardiovasc Imaging; 2016 Feb; 9(2):99-111. PubMed ID: 26684972
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Detrimental Effect of RA Pacing on LA Function and Clinical Outcome in Cardiac Resynchronization Therapy.
    Martens P; Deferm S; Bertrand PB; Verbrugge FH; Ramaekers J; Verhaert D; Dupont M; Vandervoort PM; Mullens W
    JACC Cardiovasc Imaging; 2020 Apr; 13(4):895-906. PubMed ID: 31326478
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiac resynchronization therapy in patients with permanent atrial fibrillation: results from the Resynchronization for Ambulatory Heart Failure Trial (RAFT).
    Healey JS; Hohnloser SH; Exner DV; Birnie DH; Parkash R; Connolly SJ; Krahn AD; Simpson CS; Thibault B; Basta M; Philippon F; Dorian P; Nair GM; Sivakumaran S; Yetisir E; Wells GA; Tang AS;
    Circ Heart Fail; 2012 Sep; 5(5):566-70. PubMed ID: 22896584
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A randomized controlled trial of cardiac resynchronization therapy in patients with prolonged atrioventricular interval: the REAL-CRT pilot study.
    Botto GL; Iuliano A; Occhetta E; Belotti G; Russo G; Campari M; Valsecchi S; Stabile G
    Europace; 2020 Feb; 22(2):299-305. PubMed ID: 31722381
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Continuously adjusting CRT therapy: clinical impact of adaptive cardiac resynchronization therapy.
    Houmsse M; Abraham WT
    Expert Rev Cardiovasc Ther; 2014 May; 12(5):541-8. PubMed ID: 24678730
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of chronic atrial fibrillation in patients with severe heart failure and indication for CRT: data of two registries with 711 patients (1999-2006 and 2007-6/2008).
    Luedorff G; Grove R; Kowalski M; Wolff E; Thale J; Kranig W
    Herzschrittmacherther Elektrophysiol; 2011 Dec; 22(4):226-32. PubMed ID: 22160274
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of synchronized left ventricular pacing rate on risk for ventricular tachyarrhythmias after cardiac resynchronization therapy in patients with heart failure.
    Okajima T; Inden Y; Yanagisawa S; Suga K; Shimojo M; Nakagomi T; Tsurumi N; Watanabe R; Suzuki N; Shibata R; Murohara T
    J Interv Card Electrophysiol; 2022 Oct; 65(1):239-249. PubMed ID: 35739437
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Can we rely on machines? Device-detected atrial high rates correspond well with atrial arrhythmias in cardiac resynchronization recipients.
    Jędrzejczyk-Patej E; Lenarczyk R; Mazurek M; Liberska A; Przybylska-Siedlecka K; Podolecki T; Kowalczyk J; Sokal A; Leopold-Jadczyk A; Kowalski O; Kalarus Z
    Europace; 2016 Mar; 18(3):436-44. PubMed ID: 26017467
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiac contractility modulation: first experience in heart failure patients with reduced ejection fraction and permanent atrial fibrillation.
    Röger S; Schneider R; Rudic B; Liebe V; Stach K; Schimpf R; Borggrefe M; Kuschyk J
    Europace; 2014 Aug; 16(8):1205-9. PubMed ID: 24706089
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Atrioventricular and ventricular-to-ventricular programming in patients with cardiac resynchronization therapy: results from ALTITUDE.
    Steinberg BA; Wehrenberg S; Jackson KP; Hayes DL; Varma N; Powell BD; Day JD; Frazier-Mills CG; Stein KM; Jones PW; Piccini JP
    J Interv Card Electrophysiol; 2015 Dec; 44(3):279-87. PubMed ID: 26400764
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rationale and design of the AdaptResponse trial: a prospective randomized study of cardiac resynchronization therapy with preferential adaptive left ventricular-only pacing.
    Filippatos G; Birnie D; Gold MR; Gerritse B; Hersi A; Jacobs S; Kusano K; Leclercq C; Mullens W; Wilkoff BL;
    Eur J Heart Fail; 2017 Jul; 19(7):950-957. PubMed ID: 28708290
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incidence and clinical relevance of uncontrolled ventricular rate during atrial fibrillation in heart failure patients treated with cardiac resynchronization therapy.
    Boriani G; Gasparini M; Landolina M; Lunati M; Proclemer A; Lonardi G; Iacopino S; Rahue W; Biffi M; DiStefano P; Grammatico A; Santini M;
    Eur J Heart Fail; 2011 Aug; 13(8):868-76. PubMed ID: 21558331
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improvement of left atrial function is associated with lower incidence of atrial fibrillation and mortality after cardiac resynchronization therapy.
    Fung JW; Yip GW; Zhang Q; Fang F; Chan JY; Li CM; Wu LW; Chan GC; Chan HC; Yu CM
    Heart Rhythm; 2008 Jun; 5(6):780-6. PubMed ID: 18467188
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adaptive CRT in patients with normal AV conduction and left bundle branch block: Does QRS duration matter?
    Yamasaki H; Lustgarten D; Cerkvenik J; Birnie D; Gasparini M; Lee KL; Sekiguchi Y; Varma N; Lemke B; Starling RC; Aonuma K
    Int J Cardiol; 2017 Aug; 240():297-301. PubMed ID: 28416247
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association Between the Use of an Adaptive Cardiac Resynchronization Therapy Algorithm and Health Care Use and Cost.
    Gold MR; Zhou J; Higuera L; Lanctin DP; Chung ES
    J Card Fail; 2024 Jul; ():. PubMed ID: 38977056
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.